Spike (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)

BPS Bioscience

Spike (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)

7

Neutralisation/Blocking

Research Use Only

The SARS-CoV-2 Spike Pseudotyped Lentivirus were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1) as the envelope glycoproteins instead of the commonly used VSV-G. These pseudovirions also contain the enhanced GFP gene driven by a CMV promoter, therefore, the spike-mediated cell entry can be conveniently determined via eGFP activity. The SARS-CoV-2 Spike pseudotyped lentivirus can be used to measure the activity of neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.

-80°C

41106621